Latest Nantahala Capital Management, LLC Stock Portfolio

$3.41Billion– No. of Holdings #116

Nantahala Capital Management, LLC Performance:

2024 Q2: -6.62%YTD: 0.9%2023: -2.03%

Performance for 2024 Q2 is -6.62%, and YTD is 0.9%, and 2023 is -2.03%.

About Nantahala Capital Management, LLC and 13F Hedge Fund Stock Holdings

Nantahala Capital Management, LLC is a hedge fund based in NEW CANAAN, CT. On 14-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.5 Billions. In it's latest 13F Holdings report, Nantahala Capital Management, LLC reported an equity portfolio of $3.4 Billions as of 30 Jun, 2024.

The top stock holdings of Nantahala Capital Management, LLC are SLNO, ESTA, PTON. The fund has invested 7.4% of it's portfolio in SOLENO THERAPEUTICS INC and 6.7% of portfolio in ESTABLISHMENT LABS HLDGS INC.

The fund managers got completely rid off LYRA THERAPEUTICS INC (LYRA), DYNE THERAPEUTICS INC (DYN) and GOLDEN ENTMT INC (GDEN) stocks. They significantly reduced their stock positions in DXP ENTERPRISES INC (DXPE), B. RILEY FINANCIAL INC (RILY) and RED VIOLET INC (RDVT). Nantahala Capital Management, LLC opened new stock positions in BANCORP INC DEL (TBBK), EVENTBRITE INC (EB) and OCULAR THERAPEUTIX INC (OCUL). The fund showed a lot of confidence in some stocks as they added substantially to OPTINOSE INC (OPTN), SAVARA INC (SVRA) and TELA BIO INC (TELA).

Nantahala Capital Management, LLC Equity Portfolio Value

Last Reported on: 20 Aug, 2024

Nantahala Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Nantahala Capital Management, LLC made a return of -6.62% in the last quarter. In trailing 12 months, it's portfolio return was 0.43%.

New Buys

Ticker	$ Bought
bancorp inc del	25,514,100
eventbrite inc	15,488,000
ocular therapeutix inc	13,680,000
disc medicine inc	13,521,000
astria therapeutics inc	12,285,000
avadel pharmaceuticals plc	9,842,000
centessa pharmaceuticals plc	8,127,000
context therapeutics inc	7,761,290

New stocks bought by Nantahala Capital Management, LLC

Additions

Ticker	% Inc.
optinose inc	984
savara inc	496
tela bio inc	345
the one group hospitality in	339
perfect corp	319
alta equipment group inc	316
perella weinberg partners	301
aileron therapeutics inc	264

Additions to existing portfolio by Nantahala Capital Management, LLC

Reductions

Ticker	% Reduced
dxp enterprises inc	-23.5
b. riley financial inc	-23.3
red violet inc	-18.93
immatics n.v	-11.09

Nantahala Capital Management, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
par technology corp	-4,719,900
strata skin sciences inc	-1,167,950
lyra therapeutics inc	-17,546,500
gamida cell ltd	-28,880
playags inc	-5,087,960
matterport inc	-1,239,330
dyne therapeutics inc	-12,356,900
golden entmt inc	-9,917,100

Nantahala Capital Management, LLC got rid off the above stocks

Sector Distribution

Nantahala Capital Management, LLC has about 58.4% of it's holdings in Healthcare sector.

Sector	%
Healthcare	58.4
Consumer Cyclical	12
Others	10.3
Financial Services	6
Communication Services	5.3
Technology	3.8
Industrials	2.6
Real Estate	1.6

Market Cap. Distribution

Nantahala Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
SMALL-CAP	60.1
MICRO-CAP	19.6
UNALLOCATED	9.4
MID-CAP	7.2
NANO-CAP	3.7

Stocks belong to which Index?

About 43.4% of the stocks held by Nantahala Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	56.6
RUSSELL 2000	43.4

Top 5 Winners (%)		%
NKLA	nikola corp	1315.5 %
KPRX	kiora pharmaceuticals inc	644.6 %
SSKN	strata skin sciences inc	515.7 %
SGRP	spar group inc	82.9 %
RZLT	rezolute inc	45.5 %

Top 5 Winners ($)		$
RZLT	rezolute inc	8.0 M
CASH	pathward financial inc	6.4 M
RDVT	red violet inc	5.5 M
ASRT	assertio holdings inc	5.1 M
BVS	bioventus inc	4.2 M

Top 5 Losers (%)		%
UNCY	unicycive therapeutics inc	-74.4 %
VSTM	verastem inc	-69.1 %
CONN	conns inc	-68.1 %
APTO	aptose biosciences inc	-48.0 %
ALRN	aileron therapeutics inc	-39.8 %

Top 5 Losers ($)		$
ESTA	establishment labs hldgs inc	-26.1 M
RMBL	rumbleon inc	-15.9 M
EOLS	evolus inc	-12.3 M
KROS	keros therapeutics inc	-9.5 M
CONN	conns inc	-9.3 M

Nantahala Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Nantahala Capital Management, LLC

Nantahala Capital Management, LLC has 116 stocks in it's portfolio. About 27.4% of the portfolio is in top 10 stocks. ESTA proved to be the most loss making stock for the portfolio. RZLT was the most profitable stock for Nantahala Capital Management, LLC last quarter.

Last Reported on: 20 Aug, 2024

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ABEO	abeona therapeutics inc	0.86	6,940,070	29,425,900	added	200

ACHV	achieve life sciences inc	0.18	1,308,000	6,147,600	added	100

ACRX	talphera inc	0.10	3,985,040	3,546,680	added	100

AGS	playags inc	0.00	0.00	0.00	sold off	-100

ALRN	aileron therapeutics inc	0.07	928,734	2,572,590	added	264

ALTG	alta equipment group inc	0.40	1,676,440	13,478,600	added	316

AMRX	amneal pharmaceuticals inc	0.99	5,339,890	33,908,300	added	103

ANEB	anebulo pharmaceuticals inc	0.08	1,022,150	2,790,460	added	100

ANTX	an2 therapeutics inc	0.01	196,556	422,596	added	100

APRE	aprea therapeutics inc	0.05	411,520	1,674,890	added	100

APTO	aptose biosciences inc	0.00	154,680	117,402	added	74.7

ARHS	arhaus inc	0.00	0.00	0.00	sold off	-100

ASPS	altisource portfolio solns s	0.09	2,182,020	3,076,650	added	100

ASRT	assertio holdings inc	0.67	18,541,700	22,991,700	added	100

ATXS	astria therapeutics inc	0.36	1,350,000	12,285,000	new

AURA	aura biosciences inc	0.56	2,540,070	19,202,900	added	92.16

AVTE	aerovate therapeutics inc	0.00	0.00	0.00	sold off	-100

AYTU	aytu biopharma inc	0.19	2,173,620	6,346,980	added	100

AZYO	elutia inc	0.52	3,591,390	17,813,300	added	117

BCOV	brightcove inc	0.18	2,627,540	6,227,260	new